Recombinant full-length Plasmodium falciparum circumsporozoite protein-based vaccine adjuvanted with GLA-LSQ: Results of Phase 1 testing with malaria challenge.
DeAnna J Friedman-KlabanoffAndrea A BerryMark A TravassosMallory ShriverCatherine CoxJessica ButtsJordan S LundeenKathleen A StraussSudhaunshu JoshiBiraj ShresthaAnnie X MoEffie Y H NomicosGregory A DeyeJason A RegulesElke S Bergmann-LeitnerMarcela F PasettiMatthew B LaurensPublished in: The Journal of infectious diseases (2024)
ClinicalTrials.gov Identifier NCT03589794.